Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls
Solveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 10, 2017
Central noradrenaline transporter availability in highly obese, non-depressed individuals
Swen Hesse, Georg-Alexander Becker, Michael Rullmann, et al.
Cell Metabolism
|
January 10, 2017
Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats
Mohammed K Hankir, Florian Seyfried, Constantin A Hintschich, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2024
"Metabolic fingerprints" of cachexia in lung cancer patients
Armin Frille, Jann Arends, Elisabetta M Abenavoli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 19, 2015
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study
Swen Hesse, Michael Rullmann, Julia Luthardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
Gérard N Bischof, Matthias Brendel, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2025
Exploring the origins of frequent tau-PET signal in vermal and adjacent regions
Agnes Kling, Julia Kusche-Palenga, Carla Palleis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 30, 2020
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [<sup>18</sup>F] fluspidine and [<sup>18</sup>F] fallypride PET study
Igor D Grachev, Philipp M Meyer, Georg A Becker, et al.
Imaging Neuroscience (Cambridge, Mass.)
|
August 13, 2025
Molecular connectivity studies in neurotransmission: a scoping review
Mario Severino, Débora Elisa Peretti, Marjorie Bardiau, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2024
Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies
Christian Ferschmann, Konstantin Messerschmidt, Johannes Gnörich, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls
Solveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 10, 2017
Central noradrenaline transporter availability in highly obese, non-depressed individuals
Swen Hesse, Georg-Alexander Becker, Michael Rullmann, et al.
Cell Metabolism
|
January 10, 2017
Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats
Mohammed K Hankir, Florian Seyfried, Constantin A Hintschich, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2024
"Metabolic fingerprints" of cachexia in lung cancer patients
Armin Frille, Jann Arends, Elisabetta M Abenavoli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 19, 2015
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study
Swen Hesse, Michael Rullmann, Julia Luthardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
Gérard N Bischof, Matthias Brendel, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2025
Exploring the origins of frequent tau-PET signal in vermal and adjacent regions
Agnes Kling, Julia Kusche-Palenga, Carla Palleis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 30, 2020
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [<sup>18</sup>F] fluspidine and [<sup>18</sup>F] fallypride PET study
Igor D Grachev, Philipp M Meyer, Georg A Becker, et al.
Imaging Neuroscience (Cambridge, Mass.)
|
August 13, 2025
Molecular connectivity studies in neurotransmission: a scoping review
Mario Severino, Débora Elisa Peretti, Marjorie Bardiau, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2024
Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies
Christian Ferschmann, Konstantin Messerschmidt, Johannes Gnörich, et al.
Page
of 9